0001209191-13-035485.txt : 20130703
0001209191-13-035485.hdr.sgml : 20130703
20130703164304
ACCESSION NUMBER: 0001209191-13-035485
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130702
FILED AS OF DATE: 20130703
DATE AS OF CHANGE: 20130703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 13953319
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-07-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2013-07-02
4
M
0
105000
33.00
A
249400
D
Common Stock
2013-07-02
4
M
0
9800
16.32
A
259200
D
Common Stock
2013-07-02
4
M
0
7500
18.93
A
266700
D
Common Stock
2013-07-02
4
S
0
13950
78.94
D
252750
D
Common Stock
2013-07-02
4
S
0
68985
79.52
D
183765
D
Common Stock
2013-07-02
4
S
0
39365
80.58
D
144400
D
Common Stock
4770
I
401(k)
Common Stock
5568
I
Revocable Trust
Stock Option
33.00
2013-07-02
4
M
0
105000
0.00
D
2019-10-21
Common Stock
105000
195000
D
Stock Option
16.32
2013-07-02
4
M
0
9800
0.00
D
2013-07-14
Common Stock
9800
0
D
Stock Option
18.93
2013-07-02
4
M
0
7500
0.00
D
2018-02-06
Common Stock
7500
33000
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $78.94 (range $78.82 to $79.02).
Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $79.52 (range $79.03 to $80.02).
Open market sales reported on this line occurred at a weighted average price of $80.58 (range $80.04 to $81.02).
Fully vested.
Omar White, Attorney-In-Fact
2013-07-03